DE2924692C2 - - Google Patents
Info
- Publication number
- DE2924692C2 DE2924692C2 DE2924692A DE2924692A DE2924692C2 DE 2924692 C2 DE2924692 C2 DE 2924692C2 DE 2924692 A DE2924692 A DE 2924692A DE 2924692 A DE2924692 A DE 2924692A DE 2924692 C2 DE2924692 C2 DE 2924692C2
- Authority
- DE
- Germany
- Prior art keywords
- ara
- cmp
- oleylester
- esters
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7369978A JPS552602A (en) | 1978-06-20 | 1978-06-20 | 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2924692A1 DE2924692A1 (de) | 1980-01-17 |
| DE2924692C2 true DE2924692C2 (OSRAM) | 1990-05-10 |
Family
ID=13525713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792924692 Granted DE2924692A1 (de) | 1978-06-20 | 1979-06-19 | 1- beta -d-arabinofuranosylcytosin- 5'-oleyl-phosphat und dessen salze |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4239905A (OSRAM) |
| JP (1) | JPS552602A (OSRAM) |
| DE (1) | DE2924692A1 (OSRAM) |
| FR (1) | FR2429020A1 (OSRAM) |
| GB (1) | GB2025419B (OSRAM) |
| IT (1) | IT1188839B (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS552601A (en) * | 1978-06-20 | 1980-01-10 | Yamasa Shoyu Co Ltd | Anti-tumor agent for non-injection use |
| US4314999A (en) * | 1978-07-31 | 1982-02-09 | Proter S.P.A. | N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity |
| JPS58225097A (ja) * | 1982-06-23 | 1983-12-27 | Yamasa Shoyu Co Ltd | ヌクレオシド5′−アルキルもしくはアルケニルりん酸 |
| JPS5925327A (ja) * | 1982-07-31 | 1984-02-09 | Hidematsu Hirai | 抗腫瘍性複合体の製造方法 |
| US4816570A (en) * | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
| DE4402492A1 (de) * | 1994-01-28 | 1995-08-03 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern |
| JP6294459B2 (ja) * | 2013-03-24 | 2018-03-14 | バイオカイン・セラピューティクス・リミテッドBiokine Therapeutics Ltd. | 骨髄性白血病の処置方法 |
| WO2017009842A2 (en) | 2015-07-16 | 2017-01-19 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
| BR112018016924A2 (pt) | 2016-02-23 | 2019-01-02 | Biokine Therapeutics Ltd | método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3284440A (en) * | 1964-06-12 | 1966-11-08 | Merck & Co Inc | Phosphate esters of cytosine arabinoide and process for preparing same |
| JPS535678B2 (OSRAM) * | 1973-05-30 | 1978-03-01 | ||
| GB1529974A (en) * | 1974-10-15 | 1978-10-25 | Asahi Chemical Ind | Nucleotide derivatives and process for preparing the same |
| JPS5289681A (en) * | 1976-01-22 | 1977-07-27 | Yamasa Shoyu Co Ltd | Preparation of aracytidine -5# phosphoric acid ester derivatives |
| JPS552601A (en) * | 1978-06-20 | 1980-01-10 | Yamasa Shoyu Co Ltd | Anti-tumor agent for non-injection use |
| JP3236058B2 (ja) * | 1992-04-14 | 2001-12-04 | 富士通テン株式会社 | オーディオ再生装置 |
-
1978
- 1978-06-20 JP JP7369978A patent/JPS552602A/ja active Granted
-
1979
- 1979-06-18 US US06/049,636 patent/US4239905A/en not_active Expired - Lifetime
- 1979-06-18 GB GB7921146A patent/GB2025419B/en not_active Expired
- 1979-06-18 FR FR7915501A patent/FR2429020A1/fr active Granted
- 1979-06-18 IT IT49441/79A patent/IT1188839B/it active
- 1979-06-19 DE DE19792924692 patent/DE2924692A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2025419B (en) | 1982-10-13 |
| US4239905A (en) | 1980-12-16 |
| JPS5726680B2 (OSRAM) | 1982-06-05 |
| IT7949441A0 (it) | 1979-06-18 |
| FR2429020B1 (OSRAM) | 1982-11-05 |
| JPS552602A (en) | 1980-01-10 |
| IT1188839B (it) | 1988-01-28 |
| DE2924692A1 (de) | 1980-01-17 |
| GB2025419A (en) | 1980-01-23 |
| FR2429020A1 (fr) | 1980-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3612636C2 (de) | Nucleosid-Phospholipid-Komplexe | |
| DE3152175C2 (OSRAM) | ||
| DE2924692C2 (OSRAM) | ||
| DE2924691C2 (OSRAM) | ||
| DE1695976B2 (de) | 4-Hydroxy-l- ß -D-ribofuranosyl- tetrahydro-2 (lH)-pyrimidinon, Verfahren zu seiner Herstellung und seine Verwendung | |
| DE2804099A1 (de) | Carminomycinderivate, verfahren zu ihrer herstellung und ihre verwendung | |
| CH676549A5 (OSRAM) | ||
| CH639274A5 (de) | Antikrebsmittel. | |
| DE60000590T2 (de) | Nitroimidazolderivate als Empfindlichkeitsverstärker für Chemotherapie und Radiotherapie | |
| DE2138049C3 (de) | Salze der 7- eckige Klammer auf D-2'-Phenyl-2'-aminoacetamido eckige Klammer zu-desacetoxycephalosporansäure | |
| EP0817623B1 (de) | Arzneistoffe zur selektiven bekämpfung von tumorgewebe | |
| CH621333A5 (OSRAM) | ||
| DE3424997C2 (OSRAM) | ||
| DE3228006C2 (de) | Deoxybouvardin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3041130C2 (OSRAM) | ||
| DE1237107B (de) | Verfahren zur Herstellung von Tetracyclinfusidat, des Salzes der Fusidinsaeure mit Tetracyclin | |
| DE3025656C2 (OSRAM) | ||
| DE3301489C2 (OSRAM) | ||
| EP0196330B1 (de) | Verwendung von pyrrothinderivaten | |
| DE2841898A1 (de) | Antivirales mittel auf der basis von 5-niedrigalkyl-2'-desoxyuridin-5' -monophosphaten | |
| DE2907976A1 (de) | Neue lonomycinderivate | |
| EP0152860B1 (de) | Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems | |
| DE3116250A1 (de) | "nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel" | |
| DE4419973A1 (de) | Monohydratform des (R)-2-Cycloheptylmethylaminomethyl-8-methoxy-chroman-hydrochlorids | |
| DE3122689A1 (de) | N-trifluoracetyl-adriamycin-14-0-hemiglutarat und -hemiadipat und diese enthaltende pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8128 | New person/name/address of the agent |
Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |